A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 114,939 shares of IBRX stock, worth $648,255. This represents 0.03% of its overall portfolio holdings.

Number of Shares
114,939
Holding current value
$648,255
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$4.82 - $9.15 $554,005 - $1.05 Million
114,939 New
114,939 $726 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.26B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Mirae Asset Securities (Usa) Inc. Portfolio

Follow Mirae Asset Securities (Usa) Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Securities (Usa) Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Securities (Usa) Inc. with notifications on news.